|
Market Closed -
London S.E.
11:35:20 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 6.250 GBX | +8.70% |
|
-28.57% | -60.32% |
| 09-22 | EARNINGS and TRADING: Aeorema ups guidance; ZCCM swings to profit | AN |
| 09-22 | SkinBioTherapeutics plc Provides Earnings Guidance for the Fiscal Year 2026 | CI |
| Market Cap | 16.2M 21.41M 18.83M 17.75M 30.29M 2.06B 30.53M 213M 82.56M 1.05B 80.39M 78.65M 3.4B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 19.74M 26.09M 22.95M 21.63M 36.91M 2.5B 37.2M 260M 101M 1.27B 97.95M 95.82M 4.15B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.41x |
| Free-Float |
58.8% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SBTX | Delayed | |
Deutsche Boerse AG
| 5KW | Delayed | |
|
Börse Stuttgart
| 5KW | Delayed |
Last Transcript: SkinBioTherapeutics plc
| 1 day | +8.70% | ||
| 1 week | -28.57% | ||
| Current month | -34.21% | ||
| 1 month | -34.21% | ||
| 3 months | -45.65% | ||
| 6 months | -20.38% | ||
| Current year | -60.32% |
| 1 week | 5.5 |  | 8 |
| 1 month | 5.5 | | 10 |
| Current year | 5 | | 23 |
| 1 year | 5 | | 23 |
| 3 years | 5 | | 29.5 |
| 5 years | 5 | | 78.25 |
| 10 years | 5 | | 88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rachel Parsonage
CEO | Chief Executive Officer | - | 2026-03-01 |
Anita Slater
DFI | Director of Finance/CFO | - | 2026-08-23 |
| Comptroller/Controller/Auditor | - | 2023-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2017-02-28 | |
Alyson Levett
CHM | Chairman | 60 | - |
Rachel Parsonage
BRD | Director/Board Member | - | 2026-03-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/14/23 | Buy | Chief Executive Officer | 122,517 | 0.0708% | ||
| 4/14/23 | Sell | Chief Executive Officer | 123,878 | 0.0715% | ||
| 3/9/23 | Buy | Chief Financial Officer | 86,387 | 0.0499% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.70% | -28.57% | -61.83% | -70.59% | 19.76M | |
| -3.30% | +1.19% | +54.62% | +104.15% | 74.18B | |
| -0.12% | -3.82% | +34.21% | +74.86% | 59.55B | |
| +2.31% | +5.26% | +32.50% | +21.28% | 27.63B | |
| +2.71% | -1.96% | -13.79% | +364.46% | 25.84B | |
| +0.81% | +0.61% | -0.49% | -5.14% | 24.73B | |
| -1.05% | +1.07% | +21.45% | -10.32% | 20.87B | |
| -1.70% | -3.35% | +146.86% | +325.69% | 15.32B | |
| +0.13% | +1.08% | -8.15% | +498.59% | 14.72B | |
| +2.15% | -0.92% | +48.93% | +169.79% | 14.06B | |
| Average | +1.05% | -1.89% | +25.43% | +147.28% | 27.69B | |
| Weighted average by Cap. | -0.43% | +0.58% | +35.69% | +132.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.2M 8.2M 7.21M 6.8M 11.59M 787M 11.69M 81.55M 31.6M 400M 30.77M 30.1M 1.3B | 8.2M 10.84M 9.54M 8.99M 15.34M 1.04B 15.46M 108M 41.8M 530M 40.7M 39.82M 1.72B |
| Net income | - | - |
| Net Debt | 3.54M 4.68M 4.11M 3.88M 6.62M 449M 6.67M 46.53M 18.03M 228M 17.56M 17.18M 743M | 3.57M 4.72M 4.15M 3.91M 6.68M 453M 6.73M 46.96M 18.2M 231M 17.72M 17.34M 750M |
Employees
41
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | GBX 6.250 | +8.70% | 586,245 |
| 26-09-23 | GBX 5.750 | -8.00% | 110,310,966 |
| 26-09-22 | GBX 6.250 | -16.67% | 5,457,159 |
| 26-09-21 | GBX 7.500 | -3.23% | 244,297 |
| 26-09-18 | GBX 7.750 | -11.43% | 1,034,773 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0625GBP
Average target price
0.2900GBP
Spread / Average Target
+364.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBTX Stock
Select your edition
All financial news and data tailored to specific country editions
